Stepan Company

NYSE:SCL

Chemicals - Specialty

Basic Materials
$66.05 +0.85%

+$0.46 today

Market cap
$1.50B
Beta
0.97
P/E (TTM)
-87.3
EPS (TTM)
-$0.62
Dividend yield
2.89%
52W Low $41.82High $68.00

Volume 0.13M

Average 0.15M

SCL Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Stepan CompanyNYSE: SCL

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures dips below year-ago levels

Q1 FY2026 capital expenditures of $30.89M (cash outflow) fell 5.7% year over year, behind the +356.6% change in trailing-twelve-month capital expenditures. Sequentially, it fell 66.1% from the prior quarter. Over 3 fiscal years it compounded at -25.9% a year.

Context

  • Capital expenditures amounted to 5.3% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Capital expenditures grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -5.7% toward the trailing-twelve-month pace of +356.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$30.89M-66.1% QoQ
Last fiscal yearDec 2025
-$122.51M-0.2% YoY
LTMMar 2026
-$177.13M+356.6% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.7%——
1 year-0.2%——
3-year CAGR-25.9%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(122.51M) USD
Year-over-year change
+0.2%

Capital Expenditures vs competitors

How SCL compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +356.6% is the highest of 11, against a peer median of -13.7%.
  • Capital expenditures amounts to 7.6% of revenue for SCL, versus a peer median of 6.6%.
SCL Competitors
Capital Expenditures for SCL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$3.16B BRL-10.8%-14.1%4.7%
SCLStepan CompanyLTM Mar 2026$177.13M USD+356.6%-25.9%7.6%
REXREX American Resources CorporationLTM Apr 2026$73.18M USD+37.1%+63.8%11.2%
ECVTEcovyst Inc.LTM Mar 2026$60.28M USD-20.5%+6.1%7.4%
GSMFerroglobe PLCLTM Mar 2026$58.29M USD-21.7%+5.0%4.2%
UANCVR Partners, LPLTM Mar 2026$57.98M USD+49.2%+4.4%9.0%
KOPKoppers Holdings Inc.LTM Mar 2026$52.1M USD-20.3%-19.5%2.8%
MUXMcEwen Mining Inc.LTM Mar 2026$44.66M USD-15.9%+22.7%18.9%
ODCOil-Dri Corporation of AmericaLTM Apr 2026$29M USD-11.5%+12.6%5.9%
GPREGreen Plains Inc.LTM Mar 2026$26.94M USD-70.1%-44.0%1.4%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$13.43M USD+7.6%+29.2%49.9%
Peer median (excluding SCL) —-13.7%+5.6%6.6%

Competitors are the stored peer set for SCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income137.9M147.15M40.2M50.37M46.9M
Depreciation & Amortization90.88M94.65M105.34M112.2M126.04M
Deferred Income Tax(33.61M)(27.45M)18.3M(10.29M)(1.4M)
Stock-Based Compensation11.72M13.85M5.74M5.35M2.16M
Change in Working Capital(141.51M)(68.96M)(1.93M)2.79M(22.04M)
Accounts Receivables(104.23M)(54.17M)32.01M9.04M23.72M
Inventory(79.26M)(99.39M)144.85M(37.18M)500K
Accounts Payables44.41M54.17M(158.92M)33.97M(32.71M)
Other Working Capital(2.44M)30.43M(19.86M)(3.04M)(13.55M)
Other Non-Cash Items6.76M1.53M7.22M1.64M(3.78M)
Operating Cash Flow72.14M160.76M174.88M162.05M147.88M
Capital Expenditures(194.48M)(301.55M)(260.34M)(122.78M)(122.51M)
Acquisitions (Net)(184.47M)(9.69M)0026.59M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities2.13M3.16M1.67M5.83M6.88M
Investing Cash Flow(376.83M)(308.09M)(258.67M)(116.95M)(89.05M)
Debt Repayment165M223.69M66.86M(28.69M)1.24M
Common Stock Issued002.8M1.11M104K
Common Stock Repurchased(16.97M)(24.95M)000
Dividends Paid(28.08M)(30.57M)(32.87M)(33.95M)(35.03M)
Other Financing Activities(2.62M)(1.96M)(3.5M)(3M)(1.76M)
Financing Cash Flow117.33M166.21M33.28M(64.52M)(35.44M)
Effect of Forex Changes(3.39M)(4.32M)6.58M(10.75M)9.63M
Net Change in Cash(190.75M)14.56M(43.93M)(30.16M)33.02M
Free Cash Flow(122.35M)(140.79M)(85.46M)39.28M25.37M

Stepan Company

NYSE:SCL

Intrinsic Alpha fair value

Locked

Current Price

$66.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.